CareMax Bundle
Who owns CareMax today?
CareMax went public via SPAC in June 2021 and focuses on value-based primary care for Medicare Advantage seniors. The company operates integrated clinics and assumes financial risk through capitated payer contracts. Ownership shifted after 2023–2024 restructuring and capital raises.
Major holders include public shareholders, institutional investors, strategic partners, and insiders; founder concentration is reduced and board control reflects institutional influence.
Explore a product analysis: CareMax Porter's Five Forces Analysis
Who Founded CareMax?
Founders and early ownership of CareMax trace to Miami-based clinician-operators and healthcare entrepreneurs who began building clinic assets in 2011, led by co-founder Carlos de Solo and senior Florida clinic leaders; ownership stayed concentrated with founders and physician partners through the pre-SPAC period.
Founding team
Co-founders included clinician-operators and executives, notably Carlos de Solo, who led clinical and operational strategy during early expansion.
Early clinic consolidation
Multiple Florida-centered clinic platforms were consolidated under the CareMax brand prior to the 2021 SPAC combination.
Ownership concentration
Founders and early physician partners held the majority of equity through the pre-SPAC period; precise original splits remained private.
Early investors
Regional healthcare investors and friends-and-family physician groups took minority stakes in exchange for clinic assets and patient panels.
Equity terms
Founder and management equity included multi-year and performance-based vesting tied to center openings, panel growth, and medical cost ratios.
Pre-SPAC liquidity
Pre-de-SPAC transactions converted portions of founder stakes into rollover shares and earnouts tied to post-merger share price and milestones, reducing pure founder control while aligning incentives.
By the 2021 SPAC combination, founders retained significant influence through management entities and voting arrangements, while outside capital and rollover mechanics began shifting the CareMax ownership structure toward public-market stakeholders, with founder stakes often subject to vesting and earnout conditions.
Ownership details to note
Key points on CareMax ownership and founder arrangements.
- Founders and early physician partners controlled the majority pre-SPAC; exact share splits were private.
- Early backers included regional healthcare investors and physician groups receiving minority interests for clinic contributions.
- Equity featured time- and performance-based vesting tied to openings, panel growth, and medical cost ratios.
- Pre-SPAC rollover shares and earnouts tied to post-merger share price diluted pure founder control but aligned incentives with public performance.
For deeper strategic context on the company and its market positioning see Marketing Strategy of CareMax.
CareMax SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has CareMax’s Ownership Changed Over Time?
Key events reshaping CareMax ownership include founder-led consolidation (2011–2020), the June 8, 2021 SPAC de‑SPAC with Deerfield affiliates creating NASDAQ: CMAX, subsequent PIPE financing, and 2022–2024 financing, divestiture and dilution cycles that left ownership widely dispersed by 2025.
| Period | Ownership Profile | Impact |
|---|---|---|
| 2011–2020 | Insiders, physician partners, selective private capital | Florida-centric MA primary care footprint; concentrated founder control and physician equity |
| June 8, 2021 (De‑SPAC) | Public float, Deerfield SPAC sponsors, PIPE investors, rolled founder equity | Listed as NASDAQ: CMAX; instant institutional access and liquidity |
| 2022–2023 | Growing institutional holdings, dilution of insiders, rising passive index presence | Capital needs for acquisitions; sector volatility drove portfolio rationalization |
| 2024–early 2025 | Mix of healthcare hedge funds/long‑only managers, Vanguard/BlackRock passive stakes, residual Deerfield/PIPE, insiders & RSUs | Top 10 typically under 50%; dispersed ownership, focus on unit economics and liquidity |
Ownership evolution moved from founder/physician-led private control to a diversified public holder base; by 2025 no single payer, sponsor, or founder had majority control, shaping governance and strategic priorities.
Ownership Snapshot and Drivers
Key drivers: SPAC/PIPE mechanics in 2021, post‑listing dilution from growth financing, index inclusion effects, and targeted divestitures to conserve capital.
- Founder/insider combined stakes fell to generally below 10% by late 2024 via rollovers and stock compensation
- Institutional holders (Vanguard, BlackRock and healthcare specialists) commonly held low‑ to mid‑single digits each; index funds increased passive float
- Deerfield affiliates and PIPE participants retained residual, declining stakes post‑deSPAC trading and expirations
- Top 10 holders collectively typically under 50% by 2025, indicating dispersed, market‑driven governance
Operational responses tied to ownership shifts included tightened capital allocation, portfolio exits of underperforming centers, equity/convertible financings in 2024, and intensified focus on Medicare Advantage (MA) risk performance and covenant management; see a detailed strategic review in Growth Strategy of CareMax.
CareMax PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on CareMax’s Board?
The CareMax board combines independent directors, physicians, healthcare operators and capital markets veterans, reflecting a shift from de-SPAC/PIPE-era representation toward a majority-independent board with standard public-company committees and governance practices.
| Director Category | Representation | Notes |
|---|---|---|
| Independent Directors | Majority | Chair and most committee chairs are independent; trend toward greater independence as legacy sponsor rights expire |
| Healthcare Operators & Physicians | Clinical and operational expertise | Aligned with the value-based care model and medical margin objectives |
| Capital Markets / SPAC & PIPE Representatives | Initial financing stakeholders | Historically held board seats during de-SPAC/PIPE period; turnover has reduced outsized influence |
Governance includes Audit, Compensation, and Nominating & Governance committees; voting follows one-share-one-vote with no dual-class, super-voting, or golden shares, so no single party retains special voting control.
Board composition and voting
Board composition has shifted toward independence while retaining clinicians and capital markets experience to support the VBC strategy.
- Voting is structured as one-share-one-vote; no dual-class or super-voting shares
- Committees: Audit, Compensation, Nominating & Governance are in place
- Turnover since the de-SPAC era has increased independent representation
- Investor focus in 2024–2025: capital discipline, profitable center density, and improved medical margin
Proxy voting has generally followed proxy advisor recommendations given a dispersed shareholder base with significant passive ownership; no public proxy contest has reconstituted the board, though activist scrutiny in the VBC sector has risen—major institutional holders and passive funds account for a large share of CareMax shareholders, and recent filings show top institutional stakes concentrated among healthcare-focused and index funds (latest 2025 13F filings should be consulted for exact percentages).
For historical context on formation and governance evolution see Brief History of CareMax
CareMax Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped CareMax’s Ownership Landscape?
Recent developments through 2024–2025 show CareMax ownership evolving from post‑SPAC dispersion toward a more institutionalized holder base, with founders diluted versus 2021 levels and passive index ownership rising; strategic capital actions and portfolio rationalization shifted concentration toward specialized healthcare funds while preserving one‑share‑one‑vote governance signals.
| Period | Key ownership trend | Notable metrics |
|---|---|---|
| 2021–2022 | Post‑SPAC integration; scaling increased public float and institutional participation | Share‑based compensation and earnouts modestly diluted insiders; public float expanded by an estimated ~20–30% vs. SPAC close |
| 2023 | Sector pressure prompted cost actions, equity and convertible raises; passive index inclusion rose | Insider ownership fell as % of total; passive ownership share increased after index additions; dilution from financings ranged ~5–12% |
| 2024–2025 | Portfolio rationalization, selective divestitures, secondary offerings/ATM usage and debt exchanges diversified holders | Buybacks deprioritized; center‑level margin focus improved MA risk metrics; institutional concentration in specialized funds increased |
Equity raises in 2023–2024 stabilized liquidity but reduced founder share; by mid‑2025 major institutional stakes were concentrated in healthcare ETFs and active healthcare managers, while passive ownership rose to a material fraction of free float; governance posture emphasized capital stewardship and one‑share‑one‑vote alignment.
Capital actions and dilution
Equity raises, convertibles and earnout settlements increased dilution but improved liquidity; insider percentage ownership declined relative to 2021 peaks.
Holder base diversification
Secondary offerings and ATM usage broadened the holder mix; passive index inclusion elevated ETF and index fund stakes in total shareholders.
Operational focus and strategic interest
CareMax prioritized center‑level contribution margins and MA risk performance; payers and large MSOs signaled strategic interest amid consolidation in value‑based care.
Governance and forward trends
Tendencies point to higher institutional ownership concentration in specialized healthcare funds, continued founder dilution versus 2021, and governance aligned with one‑share‑one‑vote and capital stewardship; see related context at Mission, Vision & Core Values of CareMax.
CareMax Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
- What is Brief History of CareMax Company?
- What is Competitive Landscape of CareMax Company?
- What is Growth Strategy and Future Prospects of CareMax Company?
- How Does CareMax Company Work?
- What is Sales and Marketing Strategy of CareMax Company?
- What are Mission Vision & Core Values of CareMax Company?
- What is Customer Demographics and Target Market of CareMax Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.